Receptor, Melanocortin, Type 4, agonists
- Receptor, Melanocortin, Type 4, agonists
- Accession Number
- Not Available
Drug Drug Description Bremelanotide Bremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of... Setmelanotide Setmelanotide has been investigated for the treatment of obesity. PF-00446687 PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
- Drugs & Drug Targets